Drugs Health Pharma

Fentanyl vaccine breakthrough maybe a gamechanger for opioid epidemic

Scientists have developed a vaccine against fentanyl addiction that works in rats and is ready for human trials

Read More
Drugs Health Pharma

Amazon to start virtual clinics in US

Amazon announced it would set up virtual healthcare facilities in 32 states in the US for more than 20 health conditions and acquire.

Read More
Climate Health Medical Pharma

G20 nations receive $136 million in debt daily as 828 million people face hunger: Oxfam

At a time when 828 million people are facing hunger, the G20 nations are receiving $136 million every day in debt payments from.

Read More
Drugs Pharma

FDA approves Immunogen’s drug for advanced ovarian cancer

The Food and Drug Administration approved a new treatment for patients with advanced ovarian cancer — an antibody that delivers a targeted dose.

Read More
Drugs Pharma

Roche’s Alzheimer’s drug fails to meet primary target

Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials

Read More
Drugs Pharma

Medicines to treat drug-resistant TB highly expensive for poor patients

With newer TB drugs to go off patent in 2023, MSF calls on J&J, Otsuka, to lower pricing barriers and allow generic manufacturers.

Read More
Drugs Pharma

Sanofi signs $1.2 billion drug discovery agreement with Insilico

Sanofi signs $1.2 billion drug discovery deal with AI driven drug startup Insilico

Read More
Drugs Pharma

Nitta Gelatin approves INR 1.1 billion expansion plan

The board of directors of Nitta Gelatin India has approved an INR 1.1 billion expansion plan, according to a BSE filing.

Read More
Drugs Health Pharma

Global vaccine market remains ‘highly concentrated’

Global vaccine distribution has been inequitable, and vaccines that have been prioritised by the WHO does not see the light of the day,.

Read More
Drugs Health Pharma

Viatris acquires two companies for $750 million to sharpen ophthalmology vision

Viatris acquires two companies for $750 million to fuel ophthalmology vision

Read More